Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on April 14, 2025
Immunohistochemistry Market to Reach $8.16 Billion by 2034: Digital Pathology & 8% CAGR Fuel Remarkable Growth
EIN Presswire
·
April 14, 2025
Digital pathology innovations and companion diagnostics drive 8% CAGR in market, with North America leading and Asia-Pacific showing fastest growth through 2034 US, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The global immunohistochemistry …
AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease
GlobeNewswire
·
April 14, 2025
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE Paris, April 14, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the United …
AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose
GlobeNewswire
·
April 14, 2025
COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que …
Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
GlobeNewswire
·
April 14, 2025
STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-3 reverse stock split of its outstanding shares of common stock. Cara …
Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country
GlobeNewswire
·
April 14, 2025
Saint Herblain (France), April 14, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine IXCHIQ …
Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique
GlobeNewswire
·
April 14, 2025
Saint Herblain (France), le 14 avril 2025 - Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l'agence de santé brésilienne (ANVISA) a accordé l'autorisation de mise sur le marché à son …
Prostadine Drops Reviews [We Tested It] Read Ingredients, Side Effects for Urinary System
GlobeNewswire
·
April 14, 2025
ST. PETERSBURG, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Prostadine The Natural Solution for Prostate Health - As men age, prostate health often becomes a significant concern. The prostate, a small, walnut-sized gland in the male reproductive system, plays …
Johnson & Johnson’s Oral IL-23, Icotrokinra, Poised to Redefine the Psoriasis Treatment Landscape Following Positive Phase 3 Data, According to Spherix Global Insights
GlobeNewswire
·
April 14, 2025
EXTON, PA, April 14, 2025 (GLOBE NEWSWIRE) -- Johnson …
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
GlobeNewswire
·
April 14, 2025
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate access to much-needed biosimilar to …
Positron Corporation Secures Agreement to Sell Four PET-CT Scanners
GlobeNewswire
·
April 14, 2025
Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical services, is pleased to …
Milwaukee's Underserved Communities Benefit from Outreach Community Health Center’s Use of the CHESS Health Platform
GlobeNewswire
·
April 14, 2025
Rochester, New York, April 14, 2025 (GLOBE NEWSWIRE) -- CHESS Health proudly announces a partnership with Outreach Community Health Centers (OCHC), a Federally Qualified Health Center (FQHC) based in Milwaukee, Wisconsin. This partnership is particularly …
Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month
GlobeNewswire
·
April 14, 2025
IRVING, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- In honor of Oral, Head and Neck Cancer Awareness Month, 26 U.S. Oral Surgery Management surgeon partners in seven states will offer free oral cancer screenings during the week of April 14. The screenings …
VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma
GlobeNewswire
·
April 14, 2025
— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to autologous hematopoietic cell transplantation (AHCT) — First patient dosed at City of Hope National …
NeuroOne® OneRF® Technology Success Story Featured on Fox News
GlobeNewswire
·
April 14, 2025
Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical …
Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results
GlobeNewswire
·
April 14, 2025
ATLANTA, GA, April 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA), a self-managed healthcare real estate investment company that invests primarily …
Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer
GlobeNewswire
·
April 14, 2025
Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today …
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire
·
April 14, 2025
CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
GlobeNewswire
·
April 14, 2025
Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, today announced …
Clene to Present at the Emerging Growth Conference
GlobeNewswire
·
April 14, 2025
SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to advancing therapies for …
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
GlobeNewswire
·
April 14, 2025
RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution designed to help biopharmaceutical companies lead the …